Wilko Geesink is to resign as general manager of the Dutch research-based pharmaceutical industry association, Nefarma, on December 31. He said the reason for his decision is the organizational restructuring which Nefarma is planning, and that he will remain as an adviser to the association during the transition period.
Dr Geesink, a pharmacist, has been responsible for the daily activities of Nefarma. Before joining the association, he worked for Merck Sharp & Dohme. Nefarma commented that it "appreciated the way in which Dr Geesink has advanced the interests of the Dutch research-based pharmaceutical industry on a national as well as an international level."
Nefarma's chairman, Dr J Steinert, announced his resignation earlier this year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze